SEO URLwww.firestrike.ai/deals/oxford-biomedica-bristol-myers-squibb-acquisition-2026
acquisitionAnnounced · Feb 4, 2026Chemical Manufacturing (325)Source · CredibleArticle · Factual
Bristol-Myers Squibb acquires Oxford BioMedica
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Oxford BioMedica
LON: OXIG · Oxford, Oxfordshire
Acquirer
Bristol-Myers Squibb
Status
—
Bristol-Myers Squibb agreed to acquire Oxford BioMedica. Reported deal value: Undisclosed. Status: Announced. Sector: Not specified. Target headquarters context: Oxford, Oxfordshire, United Kingdom.
This page summarizes publicly available information about the transaction as of 2026-02-04. Figures and status may change as filings and press coverage update.
Key facts : Bristol Myers Squibb Q4 net income rises ; signs deal with Oxford BioMedica ; Piper Sandler raises price target
Deal timeline
Announced
Feb 4, 2026 · tradingview.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Chemical Manufacturing (325). Figures and status may change as sources update.
Sources: tradingview.com · Primary article · FireStrike proprietary index